COVID-19-docs-english-version

2021/03/25 – 11h30

>>> COVID-19-Docs english version

Les articles de la Revue Respiratory Medicine and Research
© 2020 SPLF and Elsevier Masson SAS. All rights reserved.

• Venous thromboembolism and COVID-19  (pdf)
https://doi.org/10.1016/j.resmer.2020.100759 2590-0412
Keywords : Coronavirus disease – COVID-19 – SARS-CoV-2 – Pulmonary embolism – Venous thromboembolic disease 

• Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases (pdf)
https://doi.org/10.1016/j.resmer.2020.100768 
Keywords :

Pulmonary embolism among critically ill patients withARDS due to COVID-19 (pdf)
https://doi.org/10.1016/j.resmer.2020.100789
Keywords : 

• Proposals for managing patients with thoracic malignancies during COVID-19 pandemic (pdf)
https://doi.org/10.1016/j.resmer.2020.100769
Keywords : 

• Prognostic value of lung ultrasound and its link with inflammatory biomarkers in patients with SARS-CoV-2 infection (pdf)
https://doi.org/10.1016/j.resmer.2020.100809
Keywords : 

• Paediatric aspects of COVID-19: An update (pdf)
https://doi.org/10.1016/j.resmer.2020.100765 
Keywords :
COVID 19 – Paediatric: Clinical aspects

Nebulization: A potential source of SARS-CoV-2 transmission (pdf)
https://doi.org/10.1016/j.resmer.2020.100778 
Keywords :
Polyenes – Mucorales – Antifungal drugs – Azoles – Prophylaxis – Nebulization 

• Management of asthma during the Coronavirus disease 2019 outbreak (pdf)
https://doi.org/10.1016/j.resmer.2020.100762 
Keywords :
Asthma – Covid19 

• Letter to the Editor in response to the article: “Nebuliza-tion: a potential source of SARS-CoV-2 transmission” (pdf)
https://doi.org/10.1016/j.resmer.2020.100802 
Keywords :

• Impact of the Covid-19 pandemic and lung transplantation program in France (pdf)
https://doi.org/10.1016/j.resmer.2020.100758 
Keywords :
Lung Transplantation – COVID 19 – SARS-CoV-2 – Drug shortage – Telemedicine 

• Impact of the COVID-19 lockdown on patients suffering from idiopathic interstitial pneumonia (pdf)
https://doi.org/10.1016/j.resmer.2020.100808 
Keywords :
COVID-19 – Lockdown – Idiopathic interstitial pneumonia – Idiopathic pulmonary fibrosis 

Immunosuppression in a lung transplant recipient withCOVID-19? Lessons from an early casea (pdf)
https://doi.org/10.1016/j.resmer.2020.100782 
Keywords :
SARS-CoV-2 – Lung transplantation – Immunosuppressants – Protease inhibitors –Therapeutic drug monitoring

• Delayed pulmonary abscess following COVID-19 pneumonia: A case report  (pdf)
https://doi.org/10.1016/j.resmer.2020.100776 
Keywords : COVID-19 – Pneumonia Pulmonary abscess

• COVID-19 spread: The Italian case (pdf)
https://doi.org/10.1016/j.resmer.2020.100771 
Keywords : Covid-19 – Pneumonia 

• Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective (pdf)
https://doi.org/10.1016/j.resmer.2020.100781 
Keywords :  Coronavirus – Pulmonary hypertension – Royal Brompton Hospital London UK – Pulmonary embolism – Intensive care – ECMO – Guidelines 

COVID-19 in a patient with idiopathic pulmonary fibro-sis successfully treated with Ruxolitiniba  (pdf)
https://doi.org/10.1016/j.resmer.2020.100799
Keywords : 
SARS-CoV-2 – Covid-19 – JAK inhibitors – Idiopathic pulmonary fibrosis

COVID-19 and Pneumocystis jirovecii pneumonia: Backto the basicsa  (pdf)
https://doi.org/10.1016/j.resmer.2021.100814 
Keywords : 
COVID-19 – Pneumocystis – Jirovecii – Pneumocystosis

Covid-19: Adapting the geriatric organisations to respond to the pandemic (pdf)
https://doi.org/10.1016/j.resmer.2020.100774 
Keywords : Coronavirus disease – Covid-19SARS-CoV-2 – Elderly. 

• Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study (pdf)
https://doi.org/10.1016/j.resmer.2020.100801 

• Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges (pdf)
https://doi.org/10.1016/j.resmer.2020.100764 
Keywords :  COPD – COVID-19 – Infection 

Bronchoscopy use in the COVID-19 era (pdf)
https://doi.org/10.1016/j.resmer.2020.100760 

Alveolar lymphocytosis with plasmacytosis in severeCOVID-19 (pdf) 
https://doi.org/10.1016/j.resmer.2020.100784 
Keywords :   COVID-19 – SARS-CoV-2 – Pneumonia – Bronchoalveolar lavage fluid – Critical care 

A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavira  (pdf)
https://doi.org/10.1016/j.resmer.2020.100780 
Keywords : COVID-19 – Human immunodeficiency virus – Lopinavir – Pneumonia – Pulmonary embolism


Documents en anglais  émanants des groupes de travail  de la SPLF 

• Procedure for the pulmonary management of non-ICU patients hospitalized in the context of the COVID-19 pandemic
C. Rabec, J.Gonzalez-Bermejo for the working group (GAVO2) of SPLF
Proposals for the management of COPD patients in the context of the COVID-19 epidemic G (pdf)
Deslée, M Zysman, L Boyer, N Roche, PR Burgel
for the COPD group  Version dated 29/03/2020
Proposals for managing patients in the context of the COVID-19 pandemic (pdf)
Writing: group of experts including the French Oncology group, the SPLF and the IFCT as 
Position of the Asthma and Allergy Working Group (G2A) of the SPLF on the management of asthma patients during the COVID-19 epidemic (pdf)
Information note on the use of nebulizers during the Covid-19 epidemic (pdf)
JC Dubus, G Reychler, L Vecellio; on March 15, 2020  for the working group on aerosol therapy (GAT) of SPLF
 

Retour en haut
SPLF-APPLI

GRATUIT
VOIR